Why Researchify Health Has Incredible Impact
Cancer trials are often a patient’s best path to advanced treatment, but many never hear about them or feel ready to engage. Researchify Health bridges this gap with human-like SMS that educates, pre-screens, and coordinates next steps for both patients and caregivers. Sites keep the relationship while we automate complex Q&A, simplify eligibility workflows, and sustain interest over time—helping more patients access life-saving research faster.
Key Benefits for Oncology
Awareness to action
Two-way SMS ensures patients actually hear about relevant trials—and understand them—without intrusive calls.
Caregiver coordination
38% of oncology participants rely on a caregiver; our flows support secure, parallel communication with both.
Reduced admin load
Coordinators spend far less time collecting documents and verifying eligibility; automated pre-screening captures the right data up front.
Eligibility made simpler
Structured SMS checklists reduce screen-out from incomplete or inconsistent records.
Equity in participation
Only 15–20% of oncology trial participants come from underrepresented populations; multilingual SMS outreach ensures inclusive communication across 80+ languages
Community reach
Bring trials closer to where oncology patients receive care; SMS keeps engagement active between visits.
Meet Jane
9%
Cancer patients offered trials
<5%
Community patients in trials
38%
Rely on caregiver coordination
50%
Reduction in coordinator time
25%
Fewer incomplete submissions
15-20%
Current diverse representation
Challenges We Address
Awareness crisis: Only 9% of cancer patients are ever invited to participate in a clinical trial, despite thousands of active oncology studies nationwide
Limited access points: Fewer than 5% of community oncology patients are treated within a trial setting
Complex eligibility barriers: Up to 25% of screened oncology patients are excluded due to incomplete or inconsistent record submissions
Caregiver dependency: 38% of oncology participants rely on a caregiver for trial coordination, requiring systems that can engage both parties
Administrative burden: Coordinators spend extensive time collecting documents and verifying complex eligibility criteria
Diversity gap: Only 15–20% of oncology trial participants come from underrepresented populations, limiting trial applicability